Shopping Cart
- Remove All
Your shopping cart is currently empty
SDZ 281-977 is a derivative of Lavendustin A, an EGF receptor tyrosine kinase inhibitor.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $100 | In Stock | |
| 5 mg | $247 | In Stock | |
| 10 mg | $396 | In Stock | |
| 25 mg | $793 | In Stock | |
| 50 mg | $1,230 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $272 | In Stock |
| Description | SDZ 281-977 is a derivative of Lavendustin A, an EGF receptor tyrosine kinase inhibitor. |
| In vitro | The anticancer activity of SDZ 281-977 is evaluated in nude mice with human tumor cell lines A431 (vulvar carcinoma cells), MIA PaCa-2 (pancreatic tumor cells), and MDA-MB-231 (breast carcinoma cells). The IC50 values for growth inhibition of A431, MIA PaCa-2, and MDA-MB-231 cells are 0.21 μM, 0.29 μM, and 0.43 μM, respectively [1]. |
| In vivo | Intravenous administration of SDZ 281-977 (1-10 mg/kg) for 4 weeks in nude mice with A431 human vulvar carcinomas results in dose-dependent tumor growth inhibition. Additionally, oral administration of SDZ 281-977 (30 mg/kg) leads to a 54% inhibition of A431 tumor growth after 3 weeks of treatment [1]. |
| Synonyms | SDZ-LAP 977 |
| Molecular Weight | 316.35 |
| Formula | C18H20O5 |
| Cas No. | 150779-71-8 |
| Smiles | COC(=O)c1cc(CCc2cc(OC)ccc2OC)ccc1O |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (252.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.